Hiroyoshi Hidaka

发表

Pharmacology of protein kinase inhibitors.

H. Hidaka, H Hidaka, R. Kobayashi, 1992, Annual review of pharmacology and toxicology.

Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle.

M. Hagiwara, H. Hidaka, K. Onoda, 1988, Pharmacology.

KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.

H. Tokumitsu, M. Hagiwara, H. Hidaka, 1990, The Journal of biological chemistry.

Characterization of gamma- and delta-subunits of Ca2+/calmodulin-dependent protein kinase II in rat gastric mucosal cell populations.

H. Hidaka, M. Möhlig, M. Fährmann, 1994, The Biochemical journal.

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

H. Hidaka, S. Tochizawa, T. Sudo, 2000, Biochemical pharmacology.

Expression of protein kinase C isozyme in epidermal Langerhans cells of the mouse.

M. Hagiwara, M. Kobayashi, H. Hidaka, 1990, The Journal of investigative dermatology.

Immunocytochemical evidence for translocation of protein kinase C in human megakaryoblastic leukemic cells: synergistic effects of Ca2+ and activators of protein kinase C on the plasma membrane association

M. Hagiwara, H. Hidaka, K. Onoda, 1988, The Journal of cell biology.

A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis.

M. Hagiwara, H. Hidaka, T. Chijiwa, 1989, The Journal of biological chemistry.

Ca2+/calmodulin and cyclic 3,5' adenosine monophosphate control movement of secretory granules through protein phosphorylation/dephosphorylation in the pancreatic beta-cell.

H. Hidaka, I. Niki, M. Hisatomi, 1996, Endocrinology.

Neuroprotective properties of a protein kinase inhibitor against ischaemia‐induced neuronal damage in rats and gerbils

H. Hidaka, M. Shibuya, Y. Suzuki, 1996, British journal of pharmacology.

Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain

K. Sugita, H. Hidaka, M. Shibuya, 1991, British journal of pharmacology.

HMN-709, a chlorobenzenesulfonamide derivative, is a new membrane-permeable calmodulin antagonist.

H. Hidaka, H. Yokokura, Y. Okada, 1996, Japanese journal of pharmacology.

Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase

H. Hidaka, M. Shibuya, Y. Suzuki, 1989, British journal of pharmacology.

The effects of HA1077 on the cerebral circulation after subarachnoid haemorrhage in dogs

K. Sugita, H. Hidaka, M. Shibuya, 2005, Acta Neurochirurgica.

The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs

H. Hidaka, M. Takayasu, M. Shibuya, 2005, Acta Neurochirurgica.